New York, NY, September 18, 2013 – Palladium Capital Advisors today announced it served as the exclusive placement agent for PLC Systems Inc. $1.75 million capital raise.
PLC Systems Inc is a company focused on innovative medical device technologies. It has raised $1.75 million in gross proceeds through the sale of 29,166,668 shares of common stock at a purchase price of $0.06 per share and five-year warrants to purchase 29,166,668 shares of common stock at an exercise price of $0.08 per share. PLC Systems plans to use the proceeds from this financing to fund the ongoing U.S. pivotal trial with RenalGuard® during imaging procedures and for general corporate purposes.